Dysregulation of SMURF1 by miR-1292-5p involves in lung adenocarcinoma EMT via BMPR2/p-Smad5 signal pathway

Author:

Liu Dewei1,Li Lixia1,Xu Zhiyi1,Huang Jiawei1,Zhao Xuanna1,Chen Tingting1,Li Dongming1,Wu Bin1,Liang Zhu1,Huang Dan1,Wu Dong1

Affiliation:

1. Affiliated Hospital of Guangdong Medical University

Abstract

Abstract MicroRNAs have been shown to play a vital role in lung adenocarcinoma (LUAD) progression. In this study, we examined the underlying mechanism and biological functions of miR-1292-5p in LUAD. In LUAD tissues and cell lines, the expression of miR-1292-5p was detected using quantitative real-time polymerase chain reaction. The impact of miR-1292-5p in LUAD cells was assessed both in vitro and in vivo, while the formation of filopodia was analyzed through immunofluorescence staining. Analysis of clinical features revealed the correlation of miR-1292-5p expression and LUAD prognosis. The regulatory relationship of miR-1292-5p and SMURF1 was investigated by dual-luciferase assay and rescue experiment. The signal pathway of epithelial-to-mesenchymal transition was analyzed by western blot. The expression of miR-1292-5p, an upregulated miRNA, was detected in LUAD tissues and cell lines. Its expression showed correlation with the prognosis of LUAD. In vitro and in vivo experiments demonstrated that the overexpression of miR-1292-5p led to the promotion of migration and invasion in LUAD cells. Additionally, it induced the formation of filopodia. Mechanistically, miR-1292-5p targeted SMURF1 to regulate epithelial-to-mesenchymal transition via the BMPR2/p-Smad5 signal pathway in LUAD cells. Our study reveals that dysregulation of SMURF1 targeted by miR-1292-5p influences migration and invasion, and induces epithelial-to-mesenchymal transition by activating the BMPR2/p-Smad5 signal pathway in LUAD.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3